Information on how to access Genotropin® (somatropin, rbe) prescribing information and adverse event reporting can be found at the bottom of the page.
The products Genotropin GoQuick, Genotropin MiniQuick, and Genotropin Pen contain somatropin for the treatment of growth disturbance.1
The National Institute for Health and Care Excellence (NICE) has issued technology appraisals on the use of somatropin (recombinant growth hormone) in the treatment of growth failure in children2 and the treatment of growth hormone deficiency in adults.3
Read the NICE guidance and technology appraisal on the use of human growth hormone (somatropin) for the treatment of children with growth failure in full here.2
Somatropin is recommended as an option for treatment in children with growth failure associated with any of the following conditions:
Treatment with somatropin should be discontinued in children if any of the following apply: 2
In Prader Willi syndrome, evaluation of response to therapy should also consider body composition.
The decision to stop treatment should be made in consultation with the patient and/or carers either by:
Read the NICE guidance and technology appraisal on the use of human growth hormone (somatropin) in adults with growth hormone deficiency in full here.3
NICE has recommended that somatropin should be used for adults with severe GH deficiency that is severely affecting quality of life.3 A severe growth hormone deficiency in patients is explicitly defined as patients who:
Patients on somatropin should have their quality of life re-checked 9 months after starting treatment using the QoL-AGHDA to decide if treatment should be continued.
NICE recommends that clinicians work with patients to choose a GH product on an individual basis.
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
Somatropin is recommended in NHS England, NHS Scotland, NHS Wales and NHS Northern Ireland. Healthcare Improvement Scotland (HIS) has adopted NICE guidance.4,5
Learn more about the 3 devices available for Genotropin patients
Our dedicated nurse team are on hand to support patients being treated with Genotropin and healthcare professionals who have Genotropin patients
Contact the team
Genotropin (somatropin, rbe) 0.2mg Miniquick
Genotropin (somatropin, rbe) 0.4mg MiniQuick
Genotropin (somatropin, rbe) 0.6mg MiniQuick
Genotropin (somatropin, rbe) 0.8mg MiniQuick
Genotropin (somatropin, rbe) 1.2mg MiniQuick
Genotropin (somatropin, rbe) 1.4mg MiniQuick
Genotropin (somatropin, rbe) 1.6mg MiniQuick
Genotropin (somatropin, rbe) 1.8mg MiniQuick
Genotropin (somatropin, rbe) 12mg powder and solvent
Genotropin (somatropin, rbe) 1mg MiniQuick
Genotropin (somatropin, rbe) 2mg MiniQuick
Genotropin (somatropin, rbe) 5.3mg powder and solvent
Find out more about how Genotropin can help your patients with paediatric growth hormone deficiency
Watch this video of a teenage patient taking her daily Genotropin with the Pen
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020